TrialClinical pharmacology in drug development2026
A Phase 1 Study to Assess the Relative Bioavailability of Brigatinib Administered as an Oral Solution Versus an Immediate-Release Tablet in Healthy Adults.
Michael J Hanley et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.